Fate Therapeutics

World Rank (Jan-05-2024)

14,336

Market Cap (Jan-05-2024)

0.379 Billion USD

World Rank (Jul-30-2023)

13,932

Market Cap (Jul-30-2023)

0.414 Billion USD

World Rank (Jan-07-2022)

3,499

Market Cap (Jan-07-2022)

4.613 Billion USD

World Rank (Jan-01-2021)

1,981

Market Cap (Jan-01-2021)

8.117 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

FATE

Market Cap (Mar-08-2026)

0.16

Employee Count

449

Employee Count as of Date

As on 2021

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

55 Million USD

Annual Net Income in USD

-212 Million USD

Annual Results for Period Ending

Dec-2021 ending year

Total Assets in USD

921 Million USD

Total Liabilities in USD

242 Million USD

Total Equity in USD

678 Million USD

Balance Sheet for Period Ending

Dec-2021 ending year

Business Sector

Company Website

FATE THERAPEUTICS INC

Yahoo

Yahoo @ Frankfurt

Company Profile

Fate Therapeutics is a Clinical Stage Biopharmaceutical company. The company is dedicated to the development of next generation cellular immunotherapies for cancer and immune disorders. The headquarters is in USA.

Annual Results Summary

FATE THERAPEUTICS - Annual Results Summary - in Million USD

Year Ending:	Total Revenue	Operating Income	Net Income
Dec-2022	96	-308 (Loss)	-281 (Loss)
Dec-2021	55	-216 (Loss)	-212 (Loss)
Dec-2020	31.4	(128.1) (Loss)	(173.4) (Loss)
Dec-2019	10.7	(100.7) (Loss)	(98.1) (Loss)
Dec-2018	4.7	(67.1) (Loss)	(66.6) (Loss)
Dec-2017	4.1	(42.1) (Loss)	(43.0) (Loss)